These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 9225307

  • 1. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
    Griebel G, Perrault G, Sanger DJ.
    Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
    [Abstract] [Full Text] [Related]

  • 2. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
    Griebel G, Rodgers RJ, Perrault G, Sanger DJ.
    Neuropharmacology; 2000 Jul 24; 39(10):1848-57. PubMed ID: 10884565
    [Abstract] [Full Text] [Related]

  • 3. Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze.
    Takahashi RN, Berton O, Mormède P, Chaouloff F.
    Braz J Med Biol Res; 2001 May 24; 34(5):675-82. PubMed ID: 11323756
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G, Perrault G, Sanger DJ.
    Psychopharmacology (Berl); 1998 Jul 24; 138(1):55-66. PubMed ID: 9694527
    [Abstract] [Full Text] [Related]

  • 5. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A, Nikiforuk A.
    Neuropharmacology; 2007 Apr 24; 52(5):1274-83. PubMed ID: 17320917
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M, Siwek A, Partyka A, Kubacka M, Mogilski S, Wasik A, Kołaczkowski M, Wesołowska A.
    Neuropharmacology; 2014 Oct 24; 85():253-62. PubMed ID: 24905144
    [Abstract] [Full Text] [Related]

  • 9. Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety.
    Martin JR, Ballard TM, Higgins GA.
    Pharmacol Biochem Behav; 2002 Apr 24; 71(4):615-25. PubMed ID: 11888553
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice.
    Nic Dhonnchadha BA, Hascoët M, Jolliet P, Bourin M.
    Behav Brain Res; 2003 Dec 17; 147(1-2):175-84. PubMed ID: 14659583
    [Abstract] [Full Text] [Related]

  • 11. Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats.
    Kennett GA, Bright F, Trail B, Blackburn TP, Sanger GJ.
    Neuropharmacology; 1997 Dec 17; 36(4-5):707-12. PubMed ID: 9225297
    [Abstract] [Full Text] [Related]

  • 12. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety.
    Nic Dhonnchadha BA, Bourin M, Hascoët M.
    Behav Brain Res; 2003 Mar 18; 140(1-2):203-14. PubMed ID: 12644293
    [Abstract] [Full Text] [Related]

  • 13. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    Costall B, Naylor RJ.
    Br J Pharmacol; 1997 Nov 18; 122(6):1105-18. PubMed ID: 9401775
    [Abstract] [Full Text] [Related]

  • 14. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
    Nunes-de-Souza V, Nunes-de-Souza RL, Rodgers RJ, Canto-de-Souza A.
    Behav Brain Res; 2008 Feb 11; 187(1):72-9. PubMed ID: 17935799
    [Abstract] [Full Text] [Related]

  • 15. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
    Canto-de-Souza A, Luiz Nunes-de-Souza R, Rodgers RJ.
    Brain Res; 2002 Feb 22; 928(1-2):50-9. PubMed ID: 11844471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors.
    Gleason SD, Lucaites VL, Shannon HE, Nelson DL, Leander JD.
    Behav Pharmacol; 2001 Dec 22; 12(8):613-20. PubMed ID: 11856898
    [Abstract] [Full Text] [Related]

  • 18. Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents.
    Griebel G, Perrault G, Soubrié P.
    Psychopharmacology (Berl); 2001 Nov 22; 158(3):241-51. PubMed ID: 11713613
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.
    Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, Thomas D, Baxter GS, Forbes IT, Ham P, Blackburn TP.
    Br J Pharmacol; 1996 Feb 22; 117(3):427-434. PubMed ID: 8821530
    [Abstract] [Full Text] [Related]

  • 20. Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP.
    Durand M, Mormède P, Chaouloff F.
    Behav Pharmacol; 2003 Mar 22; 14(2):173-7. PubMed ID: 12658079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.